DiscoverESPGHAN Podcast
ESPGHAN Podcast
Claim Ownership

ESPGHAN Podcast

Author: ESPGHAN

Subscribed: 32Played: 844
Share

Description

Stay updated with the latest developments in Paediatric Gastroenterology, Hepatology, and Nutrition (PGHN) and get to know the experts behind the research and our organisation. The official podcast of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) explores cutting-edge studies, practice management strategies, and more. Join us three times a month for insightful interviews and commentary with leading professionals in the field, designed to enhance your knowledge and advance your expertise.

Our podcast features specialists from around the world, with a particular emphasis on the European community.

This podcast is hosted by the ESPGHAN Education Committee.

Disclaimer: Opinions expressed in this podcast are those of the guest invited and do not necessarily reflect the views or positions of ESPGHAN. These opinions are based on information and scientific data available at the time of recording and may change as research in the field advances.

New Episodes 1st, 10th  and 20th of the Month. For feedback, contact us: [email protected] | Playlist: ESPGHAN favourite Songs can be found on Spotify https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo

Producer: Selma Ertl, MBA | Host: Dr. Alex Knisely | Recording: Manuel Schuster

142 Episodes
Reverse
Today, listeners, please welcome to the ESPGHAN podcast Dr Jorge Amil-Dias, Emeritus Professor of Paediatrics, who retired in 2020 as Paediatric Gastroenterologist-in-Chief at the Departamento de Pediatria – Centro Hospitalar S. João, in Porto. He remains active both clinically and in ESPGHAN affairs, and today he wishes to discuss the use of proton-pump inhibitors. Four articles on this topic that he recommends are listed in the commentary accompanying today’s podcast, which you can find on the ESPGHAN website. We’ll come to that theme in due course, but first a few words about Prof Amil-Dias himself. To judge by his curriculum vitae, he is a truly hard-core Tripeiro: born in Porto, raised in Porto, educated in Porto, and successful in Porto. He would have been a gold-star Portuense had he only stayed at home between 1990 and 1991; instead, he was a research fellow and registrar at St Bartholomew's Hospital in London. Well, as the weavers’ proverb goes, only God creates perfection; every carpet must have a flaw. His list of publications is extensive, and as he progressed through the academic ranks, the range of topics he addressed broadened considerably. Among these, perhaps the most focused and coherent—and therefore, in Prof Amil-Dias’ own view, the most important—are two series of work: one contributing to the understanding of osmolality in rehydration, and the other shaping the criteria for recognising, differentiating, and treating inflammatory bowel disease, known eponymously as the Porto Criteria. Today, however, he wishes to focus on proton-pump inhibitors in children: their benefits, indications, safety, risk–benefit balance, and the public perception of treatment with these agents. Sir, welcome! Why proton-pump inhibitors today? Literature Cohen S et al. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: A 10-year literature review. Br J Clin Pharmacol. 2015 Aug;80(2):200–208. doi:10.1111/bcp.12619. Epub 2015 Jun 11. PMID: 25752807. PMCID: PMC4541968. Gieruszczak-Białek D et al. No effect of proton pump inhibitors on crying and irritability in infants: Systematic review of randomized controlled trials. J Pediatr. 2015 Mar;166(3):767–770.e3. doi:10.1016/j.jpeds.2014.11.030. Epub 2014 Dec 30. PMID: 25556017. O’Reilly D et al. Use of anti-reflux medications in infants under 1 year of age: A retrospective drug utilization study using national prescription reimbursement data. Eur J Pediatr. 2020 Dec;179(12):1963–1967. doi:10.1007/s00431-020-03837-8. Epub 2020 Oct 14. PMID: 33051717. Orel R et al. Drugs in focus: Proton pump inhibitors. J Pediatr Gastroenterol Nutr. 2021 May 1;72(5):645–653. doi:10.1097/MPG.0000000000003063. PMID: 33847286.
To start today, a few opportunities to consider, with details on the ESPGHAN website: in Rome, from 25 to 28 November 2026, the annual Young Investigator Forum; in Cluj-Napoca / Kolozsvár / Klausenburg, from 28 to 30 January 2027, a Monothematic Conference on Wilson’s disease in children. Everyone can put her or his finger on the map to point out Rome – I am ignoring the people whose fingers are on Napoli / Naples; you got Italy right, and that’s already something! – but Cluj? Well, it’s the capital of Transylvania, also known as Erdély, a very multicultural city. To get there, you go to the eastern edge of Hungary and hop across the border. I’ve visited Cluj, simply as part of getting to know Europe; I liked the town and enjoyed my long weekend there. So I recommend the venue, and of course the conference will be grand. Now to Journal Club. * * * Who will develop inflammatory bowel disease (IBD)? An important question. Prognostication, intervention… if the question can be answered, then, as with diabetes, populations at risk can be defined, screened, helped. That topic is what Dr Jake Mann wants to discuss in today’s ESPGHAN Journal Club of 2026, and who am I to deny him what he wants? Jake, as always, it’s good to be Zooming with you. Full bibliographic details for Jake’s choices are available in the documentation that accompanies this podcast – you can find it on the ESPGHAN website – so I’ll just give necessarily incomplete summaries. Work from teams at the universities of Aalborg and Aarhus, in Denmark, and at the Mount Sinai Medical Center, in Manhattan (Agrawal M et al. Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort. Clin Gastroenterol Hepatol) used data from a Danish registry that encompassed 96,817 children born between 1996 and 2002; 50,592 study participants were selected whose mothers, resident in Denmark, took part in all four interviews during pregnancy and the first two postnatal years. In approximately 21 years of follow-up, 310 offspring were diagnosed with IBD. Of these, 129 were diagnosed before the age of 17 and 43 before the age of 13; 5 had developed very-early-onset IBD, before the age of 6. A wide range of circumstances was screened for association with IBD development. The study concluded that parental IBD was a risk factor, as were early-life illness and antibiotic use (perhaps by disrupting immune-system maturation and enterobiome composition). Work from a grab-bag of Swedish and Norwegian institutions (Sigvardsson I et al. Early-life adverse events and risk of inflammatory bowel disease: a Scandinavian birth cohort study. J Pediatr Gastroenterol Nutr) enrolled twice as many children – 111,293 – with follow-up for approximately 20 years, and found a proportionately similar incidence of IBD – 697 cases. Their subjects were screened for associations between “adverse events” and later IBD. They found no evidence that such events put children at increased risk. Presented with only these summaries, one would think that the studies’ results are in diametric opposition. Identified risk; no identified risk. Clues to follow up; dead end, cul-de-sac. Is that your take-home message for us, Jake? Or do my summaries misrepresent the work done? I think the disparities arise from differences between the “adverse events” selected for study. The New Yorkers and Danes chose events impairing the body; the northern Scandinavians chose events impairing the soul. Is that your assessment, too? Literature Agrawal M, et al. Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort. Clin Gastroenterol Hepatol. 2026 Sep;24(9):2551–2559. doi:10.1016/j.cgh.2026.01.034. Epub 2026 Feb 3. PMID: 41643799. PMCID: PMC12893764 (available from 2027-02-03). Sigvardsson I, et al. Early-life adverse events and risk of inflammatory bowel disease: a Scandinavian birth cohort study. J Pediatr Gastroenterol Nutr. 2026 Aug 21. doi:10.1002/jpn3.70537. Online ahead of print. PMID: 42626830.
Amazing what one learns in readying oneself for ESPGHAN podcasts! Let me today, folks at home – or folks in office, or folks stuck in traffic, wherever you were when you said, "Right about now a podcast seems like a good idea" – start you on a journey of discovery with and about Dr Francesca Gaeta, head of paediatric gastroenterology in the Azienda Sanitaria Locale Avellino. Avellino... Say what? Italy; Campania – that region of five provinces with Naples / Napoli at the centre of its seacoast; head inland 30 miles, or 45 kilometres, to where Avellino stands, capital of the province of the same name and heart of the region of Irpinia. Googling shows that it’s a lovely area, with a rich history: If it weren’t for volcanism – daily life is one earthquake after another, with Vesuvius growling to the west – we’d all want to move to Avellino, to experience the real Italy. A quirky fact: For those whom the USA series The Sopranos, a Mafia crime drama, riveted to their television screens a quarter of a century ago, the Soprano crime-family grandparents all emigrated from Avellino. We can infer that Dr Gaeta, like all Avellinese, is a powerhouse. We’d be right to infer that: Dr Gaeta studied medicine in Salerno, a bit south of Avellino, where she also served her paediatrics residency. She then in Rome earned a master’s degree in clinical nutrition, followed by another master’s degree in childhood psychology, earned in Naples, all the while carrying out clinical duties in Avellino. And before entering medicine, she attended Avellino’s conservatory, completing a ten-year course in piano performance. Powerhouse indeed! ESPGHAN is lucky to count her as a member and a leader. Today with Dr Gaeta we’ll consider three articles that deal with food marketing, food labelling, and their effects on issues of paediatric nutrition: From Alfraidi et al., “The impact of mandatory food-marketing regulations on purchase and exposure: A narrative review”; from Chamarthi et al., “The impact of ultra-processed foods on pediatric health”; and from Smith et al., “Experimental studies of front-of-package nutrient warning labels on sugar-sweetened beverages and ultra-processed foods: A scoping review”. (The ESPGHAN website has bibliographic details.) Distinctions to bear in mind: A systematic review of a topic, such as reviews in the Cochrane compendium, collects claims and decides which can be trusted; a scoping review collects claims and presents them without rigorous assessment; and a narrative review shares opinions. Under Dr Gaeta’s guidance, we’ll explore the interface among advertising, appetite, nutrition, and health. Bring your gun and camera! Literature Alfraidi A et al. The impact of mandatory food-marketing regulations on purchase and exposure: A narrative review.Children (Basel). 2023 Jul 25;10(8):1277. doi:10.3390/children10081277. PMID: 37628276. PMCID: PMC10453145. Chamarthi VS et al. The impact of ultra-processed foods on pediatric health. Obes Pillars. 2025 Sep 9;16:100203. doi:10.1016/j.obpill.2025.100203. eCollection 2025 Dec. PMID: 41368198. PMCID: PMC12685501. Smith LS et al. Experimental studies of front-of-package nutrient warning labels on sugar-sweetened beverages and ultra-processed foods: A scoping review. Nutrients. 2020 Feb 22;12(2):569. doi:10.3390/nu12020569. PMID: 32098363. PMCID: PMC7071470. Dr Francesca Gaeta´s favourite song: Everybody Wants to Rule the World” – Tears for Fears ESPGHAN favourite Songs can be found on Spotify: https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo 
Hello, listeners! Today's guest on the ESPGHAN podcast is Prof Dr Jean-Frédéric Colombel, whose special interest is inflammatory bowel disease (IBD), and with whom today we discuss three articles titled: "Neutralizing anti-granulocyte macrophage-colony stimulating factor autoantibodies recognize post-translational glycosylations on granulocyte macrophage-colony stimulating factor years before diagnosis and predict complicated Crohn's disease"; "Prediction and prevention of inflammatory bowel disease"; and "Prediction and prevention of inflammatory bowel disease: A call to action", listed in order of their publication. (A précis of this podcast, posted at the ESPGHAN website, has full bibliographic detail.) Before taking up those articles, though, perhaps a bit of information on Prof Colombel is in order. Born in 1956 in Boulogne-sur-Mer, on the English Channel, he studied medicine in Amiens and climbed the academic ladder in Lille, where at the Centre Hospitalier Universitaire de Lille, Lille University Hospital, he rose to lead the department of hepatogastroenterology. Then, after only two years in that post, came a caesura: In 2013 he emigrated to New York, to the Upper East Side of Manhattan, where since then at Mount Sinai Medical Center he has led an IBD research-and-treatment group. Nearly sixty years of loyalty to the Hauts-de-France – what can have happened to prompt him to turn his back on his native soil? Well, people lead complicated lives, and Prof Colombel will have had his reasons to abandon moules frites, carbonade, and Maroilles. For today, however, we might set that aside and instead pose the questions: What in his analyses of mucosal immunity in IBD led to the conclusion that IBD can be predicted? If IBD can be predicted, can IBD be prevented? Prof Colombel has those answers for us, and we need only listen to learn. Literature Lee S-H et al. Prediction and prevention of inflammatory bowel disease: A call to action. Gastroenterology. 2026 Feb;170(2):233–239. doi:10.1053/j.gastro.2025.09.042. Epub 2025 Dec 18. PMID: 41410638. PMCID: PMC12862785. Lopes EW et al. Prediction and prevention of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2025 Feb;23(3):396–405.e1. doi:10.1016/j.cgh.2024.05.047. Epub 2024 Jul 10. PMID: 38996831. Mortha A et al. Neutralizing anti-granulocyte macrophage-colony stimulating factor autoantibodies recognize post-translational glycosylations on granulocyte macrophage-colony stimulating factor years before diagnosis and predict complicated Crohn's disease. Gastroenterology. 2022 Sep;163(3):659–670. doi:10.1053/j.gastro.2022.05.029. Epub 2022 May 24. PMID: 35623454. PMCID: PMC10127946.  Prof. Jean-Frédéric Colombel favourite song: Mistral gagnant” – Renaud ESPGHAN favourite Songs can be found on Spotify: https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo 
Greetings – what child of the 1960s can use that word without becoming a space alien, alighting from an interstellar craft? – "Greetings, Earthlings!" But today, of course, it's greetings to ESPGHAN podcast listeners, those logging in from other planets as well as on this one. The guest today is Prof Dr Raoul Furlano, a wearer of many hats. Most important among them is perhaps that of a member of the Guild of the Golden Star, the Zunft zum goldenen Stern, active since 1398 as the brotherhood of barber-surgeons in the city and canton of Basel. He also has sat since 2014 as member for Gross-Basel Ost in the Grand Council of the city and canton of Basel, representing the Liberal Democratic Party there. (I've visited the party's website: They seem decent sorts, if to my tastes "liberal" misrepresents their stances... but any published political programme has as its central principle, of course, only Pro bono, contra malum.) Finally, in accord with the Milizprinzip of Swiss direct participatory democracy and very much as a side-job, he is head of paediatric gastroenterology and paediatrician-in-chief at the University Hospital of Basel. For consideration today, Prof Furlano proposes three articles on aspects of endoscopy to address foreign-body ingestion: Thomson M et al., "Paediatric gastrointestinal endoscopy: European Society for Paediatric Gastroenterology Hepatology and Nutrition and European Society of Gastrointestinal Endoscopy guidelines"; Tringali A et al., "Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guideline executive summary"; and Mubarak A et al., "Diagnosis, management, and prevention of button battery ingestion in childhood: A European Society for Paediatric Gastroenterology Hepatology and Nutrition position paper." Before the listeners pause the podcast to dig out the original articles and to read along, what is the difference between the first two articles? They were published simultaneously in 2017, their author lists are largely the same: Why both of these two? These two articles include recommendations for dealing with ingestion of a variety of foreign bodies, whilst the third, from 2021, addresses only button-battery ingestion. Scuttlebutt has it that ESPGHAN has commissioned an assessment of endoscopy in foreign-body ingestion. Well, at this point listeners don't have access to a publication of the findings of that assessment. What is Prof Furlano in a position to say about those findings and about how the stances taken by ESPGHAN differ from those in the articles that he has set before us? (A quick note, listeners: Bibliographic information on the three articles is included in the précis of this podcast that can be found on the ESPGHAN website.) With that, it's off to the races! Foreign-body ingestion: What, where, how, and when! And maybe, as lagniappe, more about Swiss politics and guild Carnival parades.. Prof Furlano´s favourite song: Andrea" – Fabrizio De André ESPGHAN favourite Songs can be found on Spotify: https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo Literature Mubarak A et al. Diagnosis, management, and prevention of button battery ingestion in childhood: A European Society for Paediatric Gastroenterology Hepatology and Nutrition position paper. J Pediatr Gastroenterol Nutr. 2021 Jul 1;73(1):129–136. doi:10.1097/MPG.0000000000003048. PMID: 33555169. Thomson M et al. Paediatric gastrointestinal endoscopy: European Society for Paediatric Gastroenterology Hepatology and Nutrition and European Society of Gastrointestinal Endoscopy guidelines. J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):133–153. doi:10.1097/MPG.0000000000001408. PMID: 27622898. Tringali A et al. Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guideline executive summary.Endoscopy. 2017 Jan;49(1):83–91. doi:10.1055/s-0042-111002. Epub 2016 Sep 12. PMID: 27617420.
loading
Comments